The method of claim 7, wherein said composition further comprises a pharmaceutically acceptable carrier
Table 1: Initial use restrictions for Wegovy by commercial plans Source: Clarivate Fingertip Restrictions and payers respective prior authorization documents In addition to a relatively light hand in restricting access, Aetna, Cigna, and Anthem list Wegovy on Tier 2 of their commercial and employer formularies, reflecting widespread coverage for the drug (Fingertip Analytics, accessed February 2024)
Currently, over 1,200 GLP-1 lawsuits have been consolidated into multidistrict litigation out of the Eastern District of Pennsylvania
This reduces the chance of getting a prescription based on temporary changes
Helps prevent and treat Vitamin B12 deficiency
Experimental vascular studies indicate that BPC-157 modulates endothelial nitric oxide synthase activity by altering the interaction between endothelial nitric oxide synthase and its regulatory binding partner caveolin-1 [1][2]